Keywords: priority, review, roche, pegasys, sbla, food, drug

Priority review for Roche's Pegasys sBLA

Article | 11 October 2004

Print This

The US Food and Drug Administration has granted a six-month priority review to Roche's supplemental Biologics License Application for use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in